Literature DB >> 29976595

Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.

Stefan E Richter1,2, Loren Miller3, Daniel Z Uslan4, Douglas Bell5, Karol Watson2,6, Romney Humphries7, James A McKinnell3.   

Abstract

Infections due to colistin-resistant (Colr) Gram-negative rods (GNRs) and colistin-resistant Klebsiella pneumoniae isolates in particular result in high associated mortality and poor treatment options. To determine the risk factors for recovery on culture of Colr GNRs and ColrK. pneumoniae, analyses were chosen to aid decisions at two separate time points: the first when only Gram stain results are available without any bacterial species information (corresponding to the Colr GNR model) and the second when organism identification is performed but prior to reporting of antimicrobial susceptibility testing results (corresponding to the ColrK. pneumoniae model). Cases were retrospectively analyzed at a major academic hospital system from 2011 to 2016. After excluding bacteria that were intrinsically resistant to colistin, a total of 28,512 GNR isolates (4,557 K. pneumoniae isolates) were analyzed, 128 of which were Colr (i.e., MIC > 2 μg/ml), including 68 of which that were ColrK. pneumoniae In multivariate analysis, risk factors for Colr GNRs were neurologic disease, residence in a skilled nursing facility prior to admission, receipt of carbapenems in the last 90 days, prior infection with a carbapenem-resistant organism, and receipt of ventilatory support (c-statistic = 0.81). Risk factors for ColrK. pneumoniae specifically were neurologic disease, residence in a skilled nursing facility prior to admission, receipt of carbapenems in the last 90 days, receipt of an anti-methicillin-resistant Staphylococcus aureus antimicrobial in the last 90 days, and prior infection with a carbapenem-resistant organism (c-statistic = 0.89). A scoring system derived from these models can be applied by providers to guide empirical antimicrobial therapy in patients with infections with suspected Colr GNR and ColrK. pneumoniae isolates.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Gram-negative bacteria; Gram-negative rods; antibiotic resistance; antibiotic stewardship; antimicrobial agents; antimicrobial testing; clinical decision making; colistin

Mesh:

Substances:

Year:  2018        PMID: 29976595      PMCID: PMC6113453          DOI: 10.1128/JCM.00149-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   11.677


  34 in total

1.  Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.

Authors:  F Kontopidou; D Plachouras; E Papadomichelakis; G Koukos; I Galani; G Poulakou; G Dimopoulos; A Antoniadou; A Armaganidis; H Giamarellou
Journal:  Clin Microbiol Infect       Date:  2011-09-21       Impact factor: 8.067

Review 2.  Observational research methods. Research design II: cohort, cross sectional, and case-control studies.

Authors:  C J Mann
Journal:  Emerg Med J       Date:  2003-01       Impact factor: 2.740

3.  Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.

Authors:  D R Giacobbe; V Del Bono; E M Trecarichi; F G De Rosa; M Giannella; M Bassetti; A Bartoloni; A R Losito; S Corcione; M Bartoletti; E Mantengoli; C Saffioti; N Pagani; S Tedeschi; T Spanu; G M Rossolini; A Marchese; S Ambretti; R Cauda; P Viale; C Viscoli; M Tumbarello
Journal:  Clin Microbiol Infect       Date:  2015-08-14       Impact factor: 8.067

4.  Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.

Authors:  Belén Gutiérrez-Gutiérrez; Elena Salamanca; Marina de Cueto; Po-Ren Hsueh; Pierluigi Viale; José Ramón Paño-Pardo; Mario Venditti; Mario Tumbarello; George Daikos; Rafael Cantón; Yohei Doi; Felipe Francisco Tuon; Ilias Karaiskos; Elena Pérez-Nadales; Mitchell J Schwaber; Özlem Kurt Azap; Maria Souli; Emmanuel Roilides; Spyros Pournaras; Murat Akova; Federico Pérez; Joaquín Bermejo; Antonio Oliver; Manel Almela; Warren Lowman; Benito Almirante; Robert A Bonomo; Yehuda Carmeli; David L Paterson; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  Lancet Infect Dis       Date:  2017-04-22       Impact factor: 25.071

5.  Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.

Authors:  Isabel Machuca; Belén Gutiérrez-Gutiérrez; Irene Gracia-Ahufinger; Francisco Rivera Espinar; Ángela Cano; Julia Guzmán-Puche; Elena Pérez-Nadales; Clara Natera; Marina Rodríguez; Rafael León; Juan J Castón; Fernando Rodríguez-López; Jesús Rodríguez-Baño; Julián Torre-Cisneros
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road?

Authors:  David van Duin; Yohei Doi
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

7.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

8.  High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.

Authors:  A Capone; M Giannella; D Fortini; A Giordano; M Meledandri; M Ballardini; M Venditti; E Bordi; D Capozzi; M P Balice; A Tarasi; G Parisi; A Lappa; A Carattoli; N Petrosillo
Journal:  Clin Microbiol Infect       Date:  2012-11-09       Impact factor: 8.067

9.  Predicting Antimicrobial Resistance Prevalence and Incidence from Indicators of Antimicrobial Use: What Is the Most Accurate Indicator for Surveillance in Intensive Care Units?

Authors:  Élise Fortin; Robert W Platt; Patricia S Fontela; David L Buckeridge; Caroline Quach
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

10.  Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years.

Authors:  Flávia Rossi; Raquel Girardello; Ana Paula Cury; Thais Sabato Romano Di Gioia; João Nóbrega de Almeida; Alberto José da Silva Duarte
Journal:  Braz J Infect Dis       Date:  2016-11-08       Impact factor: 3.257

View more
  9 in total

1.  Evaluation of the MicroScan Colistin Well and Gradient Diffusion Strips for Colistin Susceptibility Testing in Enterobacteriaceae.

Authors:  Joseph D Lutgring; Anny Kim; Davina Campbell; Maria Karlsson; Allison C Brown; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

2.  Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.

Authors:  Nenad Macesic; Brian Nelson; Thomas H Mcconville; Marla J Giddins; Daniel A Green; Stephania Stump; Angela Gomez-Simmonds; Medini K Annavajhala; Anne-Catrin Uhlemann
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

3.  Molecular prevalence of resistance determinants, virulence factors and capsular serotypes among colistin resistance carbapenemase producing Klebsiella pneumoniae: a multi-centric retrospective study.

Authors:  Aradhana Das; Rajesh Kumar Sahoo; Mahendra Gaur; Suchanda Dey; Saubhagini Sahoo; Anshuman Sahu; Dibyajyoti Uttameswar Behera; Sangita Dixit; Pooja Singhvi Jain; Bhawana Jain; Kundan Kumar Sahu; K Swapna Kumari; Enketeswara Subudhi
Journal:  3 Biotech       Date:  2021-12-28       Impact factor: 2.406

4.  Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistant Acinetobacter baumannii strains: a time series analysis.

Authors:  Rania Kousovista; Christos Athanasiou; Konstantinos Liaskonis; Olga Ivopoulou; Vangelis D Karalis
Journal:  Eur J Hosp Pharm       Date:  2022-03

5.  Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.

Authors:  Po-Han Huang; Wen-Yin Chen; Sheng-Hua Chou; Fu-Der Wang; Yi-Tsung Lin
Journal:  Microbiol Spectr       Date:  2022-06-02

6.  Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods.

Authors:  Stefan E Richter; Loren Miller; Jack Needleman; Daniel Z Uslan; Douglas Bell; Karol Watson; Romney Humphries; James A McKinnell
Journal:  Open Forum Infect Dis       Date:  2019-01-23       Impact factor: 3.835

7.  Emergent Polymyxin Resistance: End of an Era?

Authors:  Zekun Li; Yuping Cao; Lingxian Yi; Jian-Hua Liu; Qiwen Yang
Journal:  Open Forum Infect Dis       Date:  2019-10-01       Impact factor: 3.835

8.  Predicting Phenotypic Polymyxin Resistance in Klebsiella pneumoniae through Machine Learning Analysis of Genomic Data.

Authors:  Nenad Macesic; Oliver J Bear Don't Walk; Itsik Pe'er; Nicholas P Tatonetti; Anton Y Peleg; Anne-Catrin Uhlemann
Journal:  mSystems       Date:  2020-05-26       Impact factor: 6.496

9.  An Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit of a Major Teaching Hospital in Chongqing, China.

Authors:  Lingyi Zeng; Chengru Yang; Jisheng Zhang; Kewang Hu; Jingbo Zou; Jie Li; Jianmin Wang; Wan Huang; Lining Yin; Xiaoli Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-06-02       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.